RxDoctor Payments Data

Dalia Shamsian

Physician Assistant · Sacramento, CANPI 1790244846

Payments from drug & device makers

$9,724in general payments, 2019–2025

Across 385 payments — averaging $25.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$2K
  • AbbVie$1K
  • Regeneron Healthcare Solutions, Inc.$919
  • Arcutis Biotherapeutics, Inc.$777
  • E.r. Squibb & Sons, L.L.C.$769
  • Lilly USA, LLC$594
  • plus $4K from 22 others

What the payments were for

  • Food & beverage$9,05593%
  • Education$6697%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,724 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa13$272,015
OtezlaApremilast28$132,750
Cosentyx Sensoready (2 Pens)Secukinumab15$113,376
Dupixent SyringeDupilumab27$103,262
Dupixent PenDupilumab24$90,221
Humira(Cf) PenAdalimumab13$89,580
OpzeluraRuxolitinib Phosphate19$41,036
ZoryveRoflumilast41$35,259
Clobetasol Propionate201$7,746
Calcipotriene31$5,456
Ivermectin14$3,260
Ketoconazole222$3,158
Fluorouracil20$1,616
Clindamycin Phosphate32$1,310
Tretinoin20$1,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$141$132,75028 claims
Incyte CorporationOpzelura$1,531$41,03619 claims
Arcutis Biotherapeutics, Inc.Zoryve$777$35,25941 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →